Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of UV-Resistant Chitosan/Starch Biofilms Reinforced with Chitosan Nanoparticles for Sustainable Packaging.

Polymers·2026
Same author

Copper-Based Metal-Organic Frameworks for Sustainable Catalysis: Mechanistic Insights, Stability, and Emerging Research Directions.

ACS omega·2026
Same author

Impact of Glucagon-Like Peptide 1 Receptor Agonists on Tacrolimus Dose-to-Concentration Ratios in Solid Organ Transplantation.

Diabetes spectrum : a publication of the American Diabetes Association·2026
Same author

Safety and Effectiveness of Tirzepatide in Solid-Organ Transplant Recipients.

Diabetes spectrum : a publication of the American Diabetes Association·2025
Same author

Inference for depending competing risks from Marshall-Olikin bivariate Kies distribution under generalized progressive hybrid censoring.

Journal of applied statistics·2025
Same author

Investigating CuO-ZrO<sub>2</sub> Mixed Metal Oxide Nanocomposites for Electrochemical Sensing of Food Colors.

Luminescence : the journal of biological and chemical luminescence·2024

Related Experiment Videos

Lower gastrointestinal bleeding: association with Sevelamer use.

Pankaj Madan, Suverta Bhayana, Prakash Chandra

    World Journal of Gastroenterology
    |April 30, 2008
    PubMed
    Summary

    Stercoral ulceration, a rare cause of lower gastrointestinal bleeding, can arise from fecal impaction. This case highlights Sevelamer-induced constipation leading to stercoral ulceration and bleeding.

    Related Experiment Videos

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Stercoral ulceration is an uncommon cause of lower gastrointestinal bleeding.
    • It results from prolonged fecal impaction exerting pressure on the colonic wall.

    Observation:

    • A case of lower gastrointestinal bleeding was investigated.
    • The bleeding was attributed to stercoral ulceration.

    Findings:

    • The stercoral ulceration was a direct consequence of Sevelamer use.
    • Sevelamer is a medication frequently associated with constipation.

    Implications:

    • This case underscores the importance of recognizing Sevelamer as a potential cause of stercoral ulceration.
    • Clinicians should consider medication side effects in patients presenting with unexplained lower gastrointestinal bleeding.